CIRM’s Key Recommendations from Strategic Allocation Framework

The California Institute for Regenerative Medicine (CIRM) presented key recommendations from its Strategic Allocation Framework (SAF), offering a structured, data‑driven approach to guide funding decisions and maximize impact. These recommendations, shared with the Independent Citizens’ Oversight Committee, move CIRM closer to its mission to accelerate the development and delivery of innovative regenerative medicine therapies. Evolving … Continue reading CIRM’s Key Recommendations from Strategic Allocation Framework

Connecting California’s research ecosystem through shared labs

A shared stem cell laboratory at UCLA In regenerative medicine (and many other fields), a lack of protocol standardization and analytical toolkits makes it difficult to access novel, reliable technology platforms. Competency hubs CIRM recognizes these limitations, and as a response, the Agency has made it a goal in the "Prop 14 era” to develop … Continue reading Connecting California’s research ecosystem through shared labs

Two California scientists advancing real-life therapies

In CIRM’s new 5-year Strategic Plan, we highlight researchers who have transformed basic discoveries into potential therapies. Joseph Wu Dr. Joseph Wu, director of the Stanford Cardiovascular Institute, has received 11 CIRM awards. Over the past decade, his lab has advanced the use of induced pluripotent stem cells for disease modeling, drug discovery, and regenerative … Continue reading Two California scientists advancing real-life therapies

Hitting our goals: Making good progress

Way, way back in 2015 – seems like a lifetime ago doesn’t it – the team at CIRM sat down and planned out our Big 6 goals for the next five years. The end result was a Strategic Plan that was bold, ambitious and set us on course to do great things or kill ourselves … Continue reading Hitting our goals: Making good progress

Hitting our Goals: Playing Matchmaker

Way, way back in 2015 – seems like a lifetime ago, doesn’t it – the team at CIRM sat down and planned out our Big 6 goals for the next five years. The end result was a Strategic Plan that was bold, ambitious, and set us on course to do great things or kill ourselves … Continue reading Hitting our Goals: Playing Matchmaker

Hitting our Goals: Let’s start at the beginning shall we

Way, way back in 2015 – seems like a lifetime ago doesn’t it – the team at CIRM sat down and planned out our Big 6 goals for the next five years. The end result was a Strategic Plan that was bold, ambitious and set us on course to do great things or kill ourselves … Continue reading Hitting our Goals: Let’s start at the beginning shall we

Budget for CIRM’s Future

The CIRM Board discusses the future of the Stem Cell Agency Last week the California Institute for Regenerative Medicine's looked at what the stem cell agency has in the back, and set out a plan to budget for CIRM's future. Last year CIRM spent about $306 million on a wide range of research. That leaves … Continue reading Budget for CIRM’s Future

Cured by Stem Cells

To get anywhere you need a good map, and you need to check it constantly to make sure you are still on the right path and haven’t strayed off course. A year ago the CIRM Board gave us a map, a Strategic Plan, that laid out our course for the next five years. Our Annual … Continue reading Cured by Stem Cells

California’s stem cell agency rounds up the year with two more big hits

It’s traditional to end the year with a look back at what you hoped to accomplish and an assessment of what you did. By that standard 2016 has been a pretty good year for us at CIRM. Yesterday our governing Board approved funding for two new clinical trials, one to help kidney transplant patients, the … Continue reading California’s stem cell agency rounds up the year with two more big hits

With an eye toward 2020, CIRM looks at clinical milestones achieved in 2016

One year ago, CIRM announced its strategic plan for the next five years. It’s a bold vision to maximize our impact in stem cell research by accelerating stem cell treatments to patients with unmet medical needs. Our strategic plan, which can be found on our website, details how CIRM will invest in five main program … Continue reading With an eye toward 2020, CIRM looks at clinical milestones achieved in 2016